Search for: "Peek v. Watson"
Results 1 - 8
of 8
Sorted by Relevance
|
Sort by Date
13 Apr 2011, 5:43 pm
The existence of the requisite calculation can include the pursuit of an “exclusive” as in Riches v News Group. [read post]
9 May 2017, 4:59 am
Yesterday afternoon, the Fourth Circuit, sitting en banc, heard two hours of argument in IRAP v. [read post]
25 Aug 2014, 8:57 am
Some district courts have permitted originators to maintain declaratory actions against a generic manufacturer (see e.g. the Second Circuit in Cephalon v Watson (2009)). [read post]
20 Jan 2024, 1:18 pm
” Meyer v. [read post]
10 Apr 2017, 3:13 am
For instance, in Texas v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
27 Apr 2017, 1:30 am
Come prepared for a lively, interactive workshop.World Café Hosts:Dayna Matthew, University of Colorado Law SchoolCharity Scott, Georgia State University College of LawSidney Watson, Saint Louis University School of LawInvited Discussants and Participants:Rodney Adams, Virginia Commonwealth University School of Health AdministrationChristina Juris Bennett, University of Oklahoma College of LawAmy Campbell, University of Memphis Cecil C. [read post]
2 Jul 2013, 1:41 pm
The other day, I was blogging about tags, and somebody asked what are all the tags. [read post]
